RWDD1抗体—艾普蒂

+ +

•  

   

     Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-2: Hela and HepG2 cell lysates, Primary antibody: P02223(RWDD1 Antibody) at dilution 1/1300, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 2 minutes    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P02223(RWDD1 Antibody) at dilution 1/220. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human tonsil tissue using P02223(RWDD1 Antibody) at dilution 1/220. (Original magnification: ×200)    

  
  

The RWDD1 (RWD Domain Containing 1) protein is a relatively understudied molecule implicated in cellular processes such as transcriptional regulation and protein-protein interactions. It contains a conserved RWD domain, a structural motif found in proteins involved in ubiquitin-like modifications, suggesting potential roles in post-translational regulatory pathways. RWDD1 has been linked to SUMOylation pathways, possibly acting as an adaptor or modulator in protein complexes that influence gene expression, stress responses, or DNA repair mechanisms.

RWDD1 antibodies are immunological tools developed to detect and study the expression, localization, and functional interactions of the RWDD1 protein. These antibodies are typically validated for applications like Western blotting, immunofluorescence, or immunohistochemistry to assess protein levels in cell lines or tissue samples. Their development aids in elucidating RWDD1's biological significance, particularly in cancer research, as altered RWDD1 expression has been observed in certain malignancies. For instance, studies suggest associations between RWDD1 polymorphisms and disease susceptibility, though mechanistic insights remain limited. Reliable antibodies enable researchers to explore its interaction partners, subcellular distribution, and potential roles in cellular stress adaptation or oncogenic signaling. Commercial antibodies often undergo specificity validation using knockout controls to minimize cross-reactivity. Continued research using these reagents could clarify RWDD1's contributions to molecular pathways and its relevance as a biomarker or therapeutic target.